Search

Jonathan D. Armstrong

Examiner (ID: 4864, Phone: (571)270-7339 , Office: P/3645 )

Most Active Art Unit
3645
Art Unit(s)
3645
Total Applications
503
Issued Applications
231
Pending Applications
107
Abandoned Applications
202

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18510102 [patent_doc_number] => 20230226202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => IL-2/IL15 COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/916363 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 527 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916363 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916363
IL-2/IL15 COMPOSITIONS AND METHODS OF USE THEREOF Mar 28, 2021 Pending
Array ( [id] => 19808329 [patent_doc_number] => 12239688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof [patent_app_type] => utility [patent_app_number] => 17/209047 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 330 [patent_figures_cnt] => 481 [patent_no_of_words] => 74475 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209047 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/209047
IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof Mar 21, 2021 Issued
Array ( [id] => 16962929 [patent_doc_number] => 20210214428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => IMMUNE CHECKPOINT THERAPY [patent_app_type] => utility [patent_app_number] => 17/204564 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6258 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204564
IMMUNE CHECKPOINT THERAPY Mar 16, 2021 Abandoned
Array ( [id] => 16930855 [patent_doc_number] => 20210196744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => COMPOSITIONS FOR CANCER THERAPY AND METHODS [patent_app_type] => utility [patent_app_number] => 17/179301 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179301 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179301
COMPOSITIONS FOR CANCER THERAPY AND METHODS Feb 17, 2021 Abandoned
Array ( [id] => 16930855 [patent_doc_number] => 20210196744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => COMPOSITIONS FOR CANCER THERAPY AND METHODS [patent_app_type] => utility [patent_app_number] => 17/179301 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179301 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179301
COMPOSITIONS FOR CANCER THERAPY AND METHODS Feb 17, 2021 Abandoned
Array ( [id] => 17186404 [patent_doc_number] => 20210333289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 17/173967 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173967 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173967
Methods of detecting and treating airway inflammatory diseases Feb 10, 2021 Issued
Array ( [id] => 17035101 [patent_doc_number] => 20210252059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => ENGINEERED SAFETY IN CELL THERAPY [patent_app_type] => utility [patent_app_number] => 17/173504 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25701 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173504 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173504
Engineered safety in cell therapy Feb 10, 2021 Issued
Array ( [id] => 17035184 [patent_doc_number] => 20210252142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/168554 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168554 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/168554
COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS Feb 4, 2021 Abandoned
Array ( [id] => 16854955 [patent_doc_number] => 20210155700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY [patent_app_type] => utility [patent_app_number] => 17/158157 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158157 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/158157
ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY Jan 25, 2021 Abandoned
Array ( [id] => 18802374 [patent_doc_number] => 11835530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Detection of microparticle-associated proteins associated with spontaneous preterm birth [patent_app_type] => utility [patent_app_number] => 17/153735 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15988 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153735 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/153735
Detection of microparticle-associated proteins associated with spontaneous preterm birth Jan 19, 2021 Issued
Array ( [id] => 16848192 [patent_doc_number] => 20210148937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE [patent_app_type] => utility [patent_app_number] => 17/153200 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 138337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153200 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/153200
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE Jan 19, 2021 Abandoned
Array ( [id] => 17300926 [patent_doc_number] => 20210396765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/152331 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152331 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152331
DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS Jan 18, 2021 Abandoned
Array ( [id] => 16791750 [patent_doc_number] => 20210121567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => PROTEIN FORMULATIONS AND METHODS OF MAKING SAME [patent_app_type] => utility [patent_app_number] => 17/137201 [patent_app_country] => US [patent_app_date] => 2020-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/137201
Protein formulations and methods of making same Dec 28, 2020 Issued
Array ( [id] => 17266430 [patent_doc_number] => 11191834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => Protein formulations and methods of making same [patent_app_type] => utility [patent_app_number] => 17/137246 [patent_app_country] => US [patent_app_date] => 2020-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 60602 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/137246
Protein formulations and methods of making same Dec 28, 2020 Issued
Array ( [id] => 16688350 [patent_doc_number] => 20210070826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/952861 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 166511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952861 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952861
Multi-chain chimeric polypeptides and uses thereof Nov 18, 2020 Issued
Array ( [id] => 19225449 [patent_doc_number] => 12005079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Biologically relevant orthogonal cytokine/receptor pairs [patent_app_type] => utility [patent_app_number] => 16/953000 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 53 [patent_no_of_words] => 16134 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953000 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/953000
Biologically relevant orthogonal cytokine/receptor pairs Nov 18, 2020 Issued
Array ( [id] => 17213176 [patent_doc_number] => 20210346512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET [patent_app_type] => utility [patent_app_number] => 16/951023 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33441 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951023 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/951023
LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET Nov 17, 2020 Abandoned
Array ( [id] => 16807894 [patent_doc_number] => 20210130447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY [patent_app_type] => utility [patent_app_number] => 17/084686 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084686 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/084686
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY Oct 29, 2020 Abandoned
Array ( [id] => 18637374 [patent_doc_number] => 11761967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-19 [patent_title] => Methods and compositions for diagnosis and prognosis of renal injury and renal failure [patent_app_type] => utility [patent_app_number] => 17/085351 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 104245 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085351 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085351
Methods and compositions for diagnosis and prognosis of renal injury and renal failure Oct 29, 2020 Issued
Array ( [id] => 16658661 [patent_doc_number] => 20210055298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure [patent_app_type] => utility [patent_app_number] => 17/085566 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23414 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085566 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085566
Methods and compositions for diagnosis and prognosis of renal injury and renal failure Oct 29, 2020 Issued
Menu